[Challenges of the antithrombotic treatment. The Danish Society for Thrombosis and Hemostasis]

Ugeskr Laeger. 2008 Mar 17;170(12):1055.
[Article in Danish]
No abstract available

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Antifibrinolytic Agents / adverse effects
  • Antifibrinolytic Agents / therapeutic use*
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Thrombolytic Therapy / adverse effects
  • Thrombosis / drug therapy*

Substances

  • Anticoagulants
  • Antifibrinolytic Agents
  • Platelet Aggregation Inhibitors